Key result
Polycystic ovary syndrome was associated with significantly lower circulating levels of CTRP5 compared to matched controls (6.90 vs 11.73 ng/mL; p<0.001).
Why the study?
Are circulating levels of CTRP5 decreased in women with polycystic ovary syndrome compared to matched controls?
Cross-Sectional (n=160)
Are circulating levels of CTRP5 decreased in women with polycystic ovary syndrome compared to matched controls?
Absolute Event Rate: 6.9% vs 11.73%
p-value: p=<0.001
Decreased circulating levels of CTRP5 are associated with a higher risk of PCOS and metabolic disturbances such as insulin resistance.
No takes yet. Share an insight, caveat, or question.
Çalan et al. (2018) conducted a cross-sectional in Polycystic ovary syndrome (PCOS) (n=160). Polycystic ovary syndrome vs. Women without PCOS was evaluated on Circulating levels of CTRP5 (ng/mL) (p=<0.001). Polycystic ovary syndrome was associated with significantly lower circulating levels of CTRP5 compared to matched controls (6.90 vs 11.73 ng/mL; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: